Europe — EMA
Obizur (Susoctocog Alfa)
Susoctocog alfa, the active ingredient in Obizur, is a recombinant factor VIII concentrate presented as an intravenous solution for intravenous use. It is used to treat hemophilia A patients with inhibitors.
Request sourcing
What is Susoctocog Alfa?
Susoctocog alfa, the active ingredient in Obizur, is a recombinant factor VIII concentrate presented as an intravenous solution for intravenous use. It is used to treat hemophilia A patients with inhibitors. GNH USA supplies Obizur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Obizur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.
What is Susoctocog Alfa used for?
Obizur is a recombinant factor VIII product that operates on the coagulation cascade and addresses hemophilia‑A related bleeding episodes.
- Hemophilia A with inhibitors: Provides temporary hemostasis for bleeding episodes and surgical procedures as needed. - Hemophilia A without the specific inhibitor ‑ used for routine on‑the‑ day management of the the . - t . - t . - t . - t - . - t . - t .
